Philip Morris lifts bid for UK's Vectura to 165 pence per share
Reuters
Published Aug 08, 2021 08:02AM ET
Updated Aug 08, 2021 10:05AM ET
(Reuters) -Philip Morris has raised its bid for British drugmaker Vectura to 165 pence ($2.29) per share, the tobacco company said on Sunday.
"The PMI (Philip Morris International (NYSE:PM)) increased offer values the entire issued and to be issued ordinary share capital of Vectura at approximately 1.02 billion pounds ($1.41 billion)," it said in an emailed statement to Reuters.
The latest offer represents a premium of approximately 10 pence per share to a rival offer of 155 pence a share by U.S.-based Carlyle Group (NASDAQ:CG) announced on Friday.
Carlyle offered to buy Vectura for about 958 million pounds ($1.3 billion).
Vectura, which makes respiratory treatments, had said on Friday that it was backing Carlyle's offer and withdrawing its recommendation for Philip Morris' proposal, adding that it might be better positioned under Carlyle's ownership.
Vectura did not immediately respond to a Reuters request for comment on Sunday.
"PMI intends to operate Vectura as an autonomous business unit that will form the backbone of its inhaled therapeutics business," Philip Morris said in the statement.
The previously agreed deal with Philip Morris came as big tobacco companies are trying to alter their image after years of negative press and lawsuits for marketing and selling health-harming cigarettes, which health advocates and experts say continues to be a leading cause of preventable deaths worldwide.
($1 = 0.7209 pounds)
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.